In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Initial public offering for Jazz Pharmaceuticals nets $100.4mm

Executive Summary

Start-up Jazz Pharmaceuticals (neurological and psychiatric diseases) netted $100.4mm in its initial public offering of 6mm common shares at $18 apiece. Earlier this month the company hoped to price the stock at $24-26 each, and later lowered the range to $20-21.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies